BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34783982)

  • 1. Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients.
    Hoeh B; Hohenhorst JL; Flammia R; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
    Int Urol Nephrol; 2022 Jan; 54(1):81-87. PubMed ID: 34783982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer.
    Chierigo F; Wenzel M; Würnschimmel C; Flammia RS; Horlemann B; Tian Z; Saad F; Chun FKH; Graefen M; Gallucci M; Shariat SF; Mantica G; Borghesi M; Suardi N; Terrone C; Karakiewicz PI
    J Urol; 2022 Feb; 207(2):375-384. PubMed ID: 34555930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients.
    Hoeh B; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
    Prostate; 2022 Jan; 82(1):120-131. PubMed ID: 34662443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.
    Bandini M; Marchioni M; Preisser F; Zaffuto E; Tian Z; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    World J Urol; 2018 Sep; 36(9):1399-1407. PubMed ID: 29717358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy.
    Wenzel M; Würnschimmel C; Chierigo F; Tian Z; Shariat SF; Terrone C; Saad F; Tilki D; Graefen M; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
    Prostate; 2021 Aug; 81(11):728-735. PubMed ID: 34010465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis.
    Knipper S; Palumbo C; Pecoraro A; Rosiello G; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
    Urol Oncol; 2020 Mar; 38(3):79.e9-79.e14. PubMed ID: 31653563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities.
    Würnschimmel C; Wenzel M; Collà Ruvolo C; Nocera L; Tian Z; Saad F; Briganti A; Shariat SF; Mandel P; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
    World J Urol; 2021 Oct; 39(10):3781-3787. PubMed ID: 33978812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy after radical prostatectomy is associated with higher other-cause mortality.
    Würnschimmel C; Wenzel M; Chierigo F; Flammia RS; Horlemann B; Tian Z; Saad F; Briganti A; Shariat SF; Gallucci M; Suardi N; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
    Cancer Causes Control; 2022 May; 33(5):769-777. PubMed ID: 35230576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns.
    Würnschimmel C; Wenzel M; Chierigo F; Flammia RS; Mori K; Tian Z; Shariat SF; Saad F; Briganti A; Suardi N; Terrone C; Gallucci M; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
    Prostate; 2021 Aug; 81(11):778-784. PubMed ID: 34057220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy.
    Wenzel M; Würnschimmel C; Chierigo F; Mori K; Tian Z; Terrone C; Shariat SF; Saad F; Tilki D; Graefen M; Mandel P; Roos FC; Chun FKH; Karakiewicz PI
    Eur Urol Focus; 2022 May; 8(3):710-717. PubMed ID: 33933420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Höh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Int Urol Nephrol; 2022 Jan; 54(1):89-95. PubMed ID: 34797483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
    Kishan AU; Karnes RJ; Romero T; Wong JK; Motterle G; Tosoian JJ; Trock BJ; Klein EA; Stish BJ; Dess RT; Spratt DE; Pilar A; Reddy C; Levin-Epstein R; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Braccioforte M; Huland H; Tran PT; Martin S; Martínez-Monge R; Krauss DJ; Abu-Isa EI; Alam R; Schwen Z; Chang AJ; Pisansky TM; Choo R; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Boutros PC; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Chong N; Kupelian PA; D'Amico AV; Rettig MB; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Horwitz EM; Tendulkar RD; Tilki D
    JAMA Netw Open; 2021 Jul; 4(7):e2115312. PubMed ID: 34196715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
    Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
    Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Prostate; 2022 May; 82(6):740-750. PubMed ID: 35226380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.
    Koo KC; Cho JS; Bang WJ; Lee SH; Cho SY; Kim SI; Kim SJ; Rha KH; Hong SJ; Chung BH
    Cancer Res Treat; 2018 Jan; 50(1):129-137. PubMed ID: 28279064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A competing risk analysis of cancer-specific mortality of initial treatment with radical prostatectomy versus radiation therapy in clinically localized high-risk prostate cancer.
    Lee JY; Cho KS; Kwon JK; Jeh SU; Kang HW; Diaz RR; Ham WS; Koom WS; Keum KC; Choi YD
    Ann Surg Oncol; 2014 Nov; 21(12):4026-33. PubMed ID: 24841351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer.
    Dell'Oglio P; Karnes RJ; Joniau S; Spahn M; Gontero P; Tosco L; Fossati N; Kneitz B; Chlosta P; Graefen M; Marchioro G; Bianchi M; Sanchez-Salas R; Karakiewicz PI; Poppel HV; Montorsi F; Briganti A;
    Urol Oncol; 2016 May; 34(5):234.e13-9. PubMed ID: 26706120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.